Bernstein initiated coverage on six pharma stocks, naming Zydus Lifesciences as its top pick, as the international brokerage holds a positive view on the Indian healthcare sector due to multiple tailwinds.
In its latest note, Bernstein gave an 'Outperform' rating to the shares of Zydus Lifesciences, Lupin and Sun Pharma. It rated Aurobindo Pharma as 'Market Perform', while the shares of Biocon and Mankind Pharma got the international brokerage's non-consensus 'Underperform' call.